BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 35899490)

  • 21. The Incidence of Drug- and Herbal and Dietary Supplement-Induced Liver Injury: Preliminary Findings from Gastroenterologist-Based Surveillance in the Population of the State of Delaware.
    Vega M; Verma M; Beswick D; Bey S; Hossack J; Merriman N; Shah A; Navarro V;
    Drug Saf; 2017 Sep; 40(9):783-787. PubMed ID: 28555362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study.
    Molleston JP; Fontana RJ; Lopez MJ; Kleiner DE; Gu J; Chalasani N;
    J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):182-9. PubMed ID: 21788760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct.
    Fontana RJ; Watkins PB; Bonkovsky HL; Chalasani N; Davern T; Serrano J; Rochon J;
    Drug Saf; 2009; 32(1):55-68. PubMed ID: 19132805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center.
    Ettel M; Gonzalez GA; Gera S; Eze O; Sigal S; Park JS; Xu R
    Hum Pathol; 2017 Oct; 68():92-98. PubMed ID: 28873351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases From the Drug-Induced Liver Injury Network.
    Barritt AS; Barnhart H; Gu J; Dellinger A; Rudnick S; Bonkovsky HL;
    Am J Gastroenterol; 2023 Dec; 118(12):2301-2304. PubMed ID: 37311048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and prevalence of acute hepatitis E virus infection in patients with suspected Drug-Induced Liver Injury in the Spanish DILI Registry.
    Sanabria-Cabrera J; Sanjuán-Jiménez R; Clavijo E; Medina-Cáliz I; González-Jiménez A; García-Cortés M; Ortega-Alonso A; Jiménez-Pérez M; González-Grande R; Stephens C; Robles-Díaz M; Lucena MI; Andrade RJ;
    Liver Int; 2021 Jul; 41(7):1523-1531. PubMed ID: 33107176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-Induced Liver Injury: Highlights of the Recent Literature.
    Real M; Barnhill MS; Higley C; Rosenberg J; Lewis JH
    Drug Saf; 2019 Mar; 42(3):365-387. PubMed ID: 30343418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs.
    Urban TJ; Shen Y; Stolz A; Chalasani N; Fontana RJ; Rochon J; Ge D; Shianna KV; Daly AK; Lucena MI; Nelson MR; Molokhia M; Aithal GP; Floratos A; Pe'er I; Serrano J; Bonkovsky H; Davern TJ; Lee WM; Navarro VJ; Talwalkar JA; Goldstein DB; Watkins PB; ; ; ; ;
    Pharmacogenet Genomics; 2012 Nov; 22(11):784-95. PubMed ID: 22968431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-induced liver injury: an overview over the most critical compounds.
    Björnsson ES
    Arch Toxicol; 2015 Mar; 89(3):327-34. PubMed ID: 25618544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics of antiepileptic-induced liver injury in patients from the DILIN prospective study.
    Chalasani N; Bonkovsky HL; Stine JG; Gu J; Barnhart H; Jacobsen E; Björnsson E; Fontana RJ; Kleiner DE; Hoofnagle JH;
    J Hepatol; 2022 Apr; 76(4):832-840. PubMed ID: 34953957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver injury caused by oral anticoagulants: A population-based retrospective cohort study.
    Björnsson HK; Gudmundsson DO; Björnsson ES
    Liver Int; 2020 Aug; 40(8):1895-1900. PubMed ID: 32511827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology and risk factors for idiosyncratic drug-induced liver injury.
    Björnsson ES
    Semin Liver Dis; 2014 May; 34(2):115-22. PubMed ID: 24879977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.
    Xu HM; Chen Y; Xu J; Zhou Q
    World J Gastroenterol; 2012 Nov; 18(41):5972-8. PubMed ID: 23139615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relapse and Need for Extended Immunosuppression: Novel Features of Drug-Induced Autoimmune Hepatitis.
    Weber S; Gerbes AL
    Digestion; 2023; 104(3):243-248. PubMed ID: 36603570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.
    Chalasani N; Fontana RJ; Bonkovsky HL; Watkins PB; Davern T; Serrano J; Yang H; Rochon J;
    Gastroenterology; 2008 Dec; 135(6):1924-34, 1934.e1-4. PubMed ID: 18955056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management.
    Björnsson HK; Björnsson ES
    Eur J Intern Med; 2022 Mar; 97():26-31. PubMed ID: 34772600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Epidemiology of Newly Recognized Causes of Drug-Induced Liver Injury: An Update.
    Björnsson ES
    Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secular Trends in Severe Idiosyncratic Drug-Induced Liver Injury in North America: An Update From the Acute Liver Failure Study Group Registry.
    Rao A; Rule JA; Hameed B; Ganger D; Fontana RJ; Lee WM
    Am J Gastroenterol; 2022 Apr; 117(4):617-626. PubMed ID: 35081550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults.
    Yeboah-Korang A; Memon A; Patel N; Portocarrero-Castillo A; Osman A; Kleesattel D; Lopez C; Louissaint J; Sherman K; Fontana R
    Dig Dis Sci; 2022 Nov; 67(11):5262-5271. PubMed ID: 35122190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study.
    Nicoletti P; Aithal GP; Bjornsson ES; Andrade RJ; Sawle A; Arrese M; Barnhart HX; Bondon-Guitton E; Hayashi PH; Bessone F; Carvajal A; Cascorbi I; Cirulli ET; Chalasani N; Conforti A; Coulthard SA; Daly MJ; Day CP; Dillon JF; Fontana RJ; Grove JI; Hallberg P; Hernández N; Ibáñez L; Kullak-Ublick GA; Laitinen T; Larrey D; Lucena MI; Maitland-van der Zee AH; Martin JH; Molokhia M; Pirmohamed M; Powell EE; Qin S; Serrano J; Stephens C; Stolz A; Wadelius M; Watkins PB; Floratos A; Shen Y; Nelson MR; Urban TJ; Daly AK;
    Gastroenterology; 2017 Apr; 152(5):1078-1089. PubMed ID: 28043905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.